Heidelberg Pharma AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '25 Dec 3, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2019 - 2015
Market Capitalization	132	112	129	266	177	162	Upgrade
Market Cap Growth	29.71%	-13.03%	-51.73%	50.53%	9.59%	159.56%	Upgrade
Enterprise Value	110	75	84	272	164	153	Upgrade
Last Close Price	2.76	2.31	2.71	5.58	5.16	5.22	Upgrade
PS Ratio	43.59	16.33	13.05	14.39	87.04	18.64	Upgrade
PB Ratio	12.57	3.62	2.61	4.00	26.43	12.54	Upgrade
P/TBV Ratio	78.20	5.08	3.18	4.62	-	40.90	Upgrade
EV/Sales Ratio	36.10	11.02	8.49	14.68	80.41	17.60	Upgrade
Debt / Equity Ratio	0.01	0.01	0.12	0.24	1.59	0.02	Upgrade
Asset Turnover	0.05	0.11	0.12	0.30	0.10	0.41	Upgrade
Inventory Turnover	0.03	0.16	0.43	1.76	9.66	23.96	Upgrade
Quick Ratio	3.48	4.42	2.31	2.96	0.51	0.98	Upgrade
Current Ratio	5.85	5.95	2.86	3.15	0.60	1.14	Upgrade
Return on Equity (ROE)	-112.95%	-48.33%	-35.09%	-53.73%	-267.02%	-125.93%	Upgrade
Return on Assets (ROA)	-32.31%	-20.82%	-20.14%	-18.70%	-78.14%	-56.00%	Upgrade
Return on Capital (ROIC)	-83.00%	-31.65%	-24.99%	-22.88%	-106.22%	-81.22%	Upgrade
Return on Capital Employed (ROCE)	-65.80%	-41.40%	-54.50%	-25.20%	-380.20%	-147.00%	Upgrade
Earnings Yield	-19.77%	-17.33%	-15.82%	-7.39%	-14.77%	-11.37%	Upgrade
FCF Yield	-24.17%	-26.86%	-26.91%	-3.55%	-15.74%	-11.92%	Upgrade
Buyback Yield / Dilution	-2.26%	-0.02%	-25.14%	-14.56%	-8.72%	-5.98%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.